Dataset– tag –
-
Market Trends
EU AI Act Reshapes Generative AI Copyright: Curtis Law Firm Details New Legal Challenges and Compliance Pathways
Curtis, Mallet-Prevost, Colt & Mosle LLP International Overview International law firm Curtis, Mallet-Prevost, Colt & Mosle LLP has released a comprehensive analysis detailing the new legal challenges and compliance requirements for ... -
New Technology
SiliconFlow Launches Real-Time LLM Benchmarking Platform, Aiming for Industry Standardization
SiliconFlow International Overview SiliconFlow has unveiled a cutting-edge real-time benchmarking tool for large language models (LLMs), enabling comprehensive evaluation of inference speed, accuracy, and cost-efficiency. This platform p... -
Market Trends
Europe’s AI Act: Stringent Obligations for High-Risk Systems Go Live in 2026
Wirtek Denmark Overview Effective August 2, 2026, the EU AI Act will impose its most critical regulations on high-risk AI systems listed under Annex III. This landmark legislation, which came into force on August 1, 2024, mandates strict... -
New Technology
Ant Group’s Robbyant Launches LingBot-VA 2.0: Industry-First Embodied-Native Video-Action World Model for Physical World Control in Robotics
Business Wire (Ant Group) China Overview On July 9, 2026, Robbyant, Ant Group's embodied AI firm, released LingBot-VA 2.0, the industry's first embodied-native video-action world model. This launch signals a pivotal shift in robotics fou... -
New Technology
AI Biologics Drug Discovery Accelerates: Earendil Labs Secures $787 Million for AI Platform Development
IntuitionLabs Unknown Overview By 2026, the convergence of AI and biologics drug discovery has dramatically accelerated, marking a significant inflection point in pharmaceutical R&D. Earendil Labs, a novel AI-driven biologics startup... -
New Technology
High-Quality Patient Data is Key to AI’s Clinical Trial Transformation: Deepening Gene Expression and Molecular Pathway Analysis
Clinical Leader USA Overview A Clinical Leader article asserts that more high-quality patient data is essential for AI to truly transform clinical trials. New technologies now generate rich, unbiased data on gene expression, protein acti... -
Market Trends
SK bioscience Leads Gates Foundation-Funded AI Platform ‘ROTOR’ to Enhance Vaccine Development Decisions, Focusing on Next-Gen Rotavirus Vaccines
PR Newswire South Korea Overview SK bioscience is leading the Gates Foundation-funded ROTOR project, an AI-powered platform for evidence-based clinical development decision-making in vaccine development, with PATH and Slalom as global co... -
New Technology
Synthetic Data Revolutionizes AI Quality Inspection Training, Solving the ‘Cold-Start Problem’ for Rare Defects in Manufacturing
zetamotion.com USA Overview Synthetic data is emerging as a crucial tool for training AI inspection models, particularly for rare or hard-to-reproduce defects in manufacturing quality control. This approach enables manufacturers to creat... -
New Technology
AWS Introduces “Nova Pro” Zero-Shot Defect Detection and Agentic AI for Autonomous Factories
AWS USA Overview AWS is driving autonomous factory development with software-defined AI solutions, integrating AI-powered automation, agentic orchestration, and automated quality inspection. Its Amazon Nova Pro vision-based defect detect... -
Market Trends
Healthcare AI Governance Faces Hurdles from Regulatory Overlap and Patient Opt-Out, HIMSS Advocates Comprehensive Data Governance
Medical Buyer India Overview Effective AI governance in healthcare is hampered by regulatory overlap, patient opt-out laws, and fragmented datasets. At the HIMSS AI in Healthcare Forum, panelists emphasized the critical need for healthca...